NCT02699593 is a NA clinical trial of Test Contact Lens in Visual Acuity, sponsored by Johnson & Johnson Vision Care, Inc..

Who is sponsoring NCT02699593?

NCT02699593 is sponsored by Johnson & Johnson Vision Care, Inc..

What drugs are being tested in NCT02699593?

Interventions in NCT02699593: Test Contact Lens, Control Contact Lens.

What condition does NCT02699593 study?

NCT02699593 studies Visual Acuity.

Is NCT02699593 still recruiting?

NCT02699593 is currently completed. Last updated 12 July 2017.

Are results published for NCT02699593?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2017-07-12 · How we verify

NCT02699593

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of Approved Contact Lenses

Completed NA Results posted Last updated 12 July 2017

What this trial tests

NA trial testing Test Contact Lens in Visual Acuity in 142 participants. Completed in 1 April 2016.

Timeline

1 February 2016

Primary endpoint
1 April 2016

1 April 2016

Quick facts

Lead sponsor	Johnson & Johnson Vision Care, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	basic science
Enrollment	142
Start date	1 February 2016
Primary completion	1 April 2016
Estimated completion	1 April 2016
Sites	7 locations across United States

Drugs / interventions tested

Test Contact Lens
Control Contact Lens

Conditions studied

Visual Acuity — all drugs for Visual Acuity →

Sponsor

Johnson & Johnson Vision Care, Inc. — full company profile →

Who can join

Adults 18 to 70, any sex, with Visual Acuity. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Contact Lens Wearing Time Primary · 2-week follow-up

Contact lens wearing time was collected for each subject at the 2-week follow-up evaluation. The average contact lens wearing time in hours was reported for each lens.

Group	Value	95% CI
Senofilcon A (Test)	14.55	± 1.534
Senofilcon A (Control)	14.63	± 1.516

Visual Acuity (LogMAR) Primary · 2-week Follow-up

Distance Visual Acuity (LogMAR) was assessed using an ETDRS chart at the 2-week follow-up for each subject and eye for 2 conditions, Bright low contrast and Dim high contrast. The average visual acuity (LogMAR) for each condition and lens was reported.

Bright Low Contrast

Group	Value	95% CI
Senofilcon A (Test)	0.121	± 0.0905
Senofilcon A (Control)	0.122	± 0.0881

Dim High Contrast

Group	Value	95% CI
Senofilcon A (Test)	0.086	± 0.0874
Senofilcon A (Control)	0.089	± 0.0846

Sponsor's own description

This is a 4-week, randomized, double-masked study where subjects will wear bilaterally test and control lenses in random succession. The objective is to evaluate materials from different suppliers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Test Contact Lens

Trials testing the same drug.

NCT04492397 — Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI) · NA · completed
NCT03306641 — A One-Week Crossover Dispensing Evaluation of New Daily Wear Soft Contact Lenses · NA · completed

Other recruiting trials for Visual Acuity

Currently open trials in the same condition.

NCT07443215 — Evaluation of Effect of Scatter on Visual Performance · NA · recruiting
NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath · NA · active not recruiting
NCT07085533 — Natural History Study of Inherited Retinal Diseases · recruiting
NCT07135180 — Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups · NA · active not recruiting
NCT04632901 — A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA) · active not recruiting

Other Johnson & Johnson Vision Care, Inc. trials

Trials by the same sponsor.

NCT07443215 — Evaluation of Effect of Scatter on Visual Performance · NA · recruiting
NCT07174596 — Evaluation of Approved Contact Lenses · NA · completed
NCT07076160 — Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses · NA · completed
NCT06967129 — Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process · NA · completed
NCT06864858 — Clinical Evaluation of Two Cosmetic Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02699593 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Vision Care, Inc.
Last refreshed: 12 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02699593.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing